Groundbreaking discovery! Prostrate cancer development linked to Five “Mutants.”
Let us meet LEPR, CRY1, RNASEL, IL4, and ARVCF! Researchers have identified these five new gene variants, or mutations that
Read moreLet us meet LEPR, CRY1, RNASEL, IL4, and ARVCF! Researchers have identified these five new gene variants, or mutations that
Read moreOn Tuesday, Abbott Laboratories announced that two longer-acting doses of Lupron, a treatment for premature puberty, have been approved by
Read moreThe first multi-institutional study to assess a new form of radiation treatment for prostate cancer along with sophisticated real-time tumor
Read more